FIRST BERLIN Equity Research

Similar documents
5 November C Solarparken AG. FIRST BERLIN Equity Research

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research

Deutsche Biotech Innovativ AG

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

Intershop Communications AG

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

18 October 2016 aventron AG. FIRST BERLIN Equity Research

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

26 April 2017 aventron AG. FIRST BERLIN Equity Research

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

Advanced Vision Technology

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

ad pepper media International N.V.

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

Schloss Wachenheim AG

7 March 2017 Sirona Biochem Corp. FIRST BERLIN Equity Research FY16. PRICE TARGET C$0.95 Secondary: Quotation Board Frankfurt.

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

8 May 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 36.3% ISIN: DE000A1EWVY8

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

Chow Tai Fook (1929 HK)

Deutsche Biotech Innovativ AG

Advanced Vision Techn Buy

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

18 May 2018 Energiekontor AG. FIRST BERLIN Equity Research

Petro Rabigh Shutdown marred Q2 results

Fila Korea (081660) Widespread growth potential

FIRST BERLIN. CCR Logistics Systems AG. Rating: Strong Buy 2005 Price Target: 9.33 Risk Rating: Medium. Update: FY2004 Results

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

BDI BioEnergy Internat Buy

Almonty Industries inc.

Company Overview. Industry Overview. Financial Performance

16 April 2018 Epigenomics AG. FIRST BERLIN Equity Research. Update. Bloomberg: ECX Return Potential 96.9% ISIN: DE000A11QW50

9 November 2018 Valneva SE. FIRST BERLIN Equity Research

Anta Sports (2020 HK)

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary

Chow Sang Sang (116 HK)

Chow Tai Fook (1929 HK)

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer

Sunway Unlocking value in construction

Luk Fook (590 HK) Hold (maintained) Target price: HK$ In line results, 1QFY17 remains weak. Equity Research Consumer Discretionary.

Yansab Better than expected results

28 March 2019 PAION AG. FIRST BERLIN Equity Research

Company Overview. Financial Performance

ISRA VISION Neutral

27 February 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research. Smart Meter Gateway BENEFITING FROM DIGITISATION OF HEALTH AND ENERGY MARKETS

SABIC Overall strong performance

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

Almonty Industries inc.

Company Overview. Industry Overview. Financial Performance

12 December 2018 Pharming Group NV. FIRST BERLIN Equity Research. acute HAE therapies HEAD-TO-HEAD STUDY GIVES PHARMING NEW WEAPON AGAINST FIRAZYR

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

MPH Mittelstaendische Pharma Holding AG M P

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

China TCM (570 HK) Buy (maintained) Target price: HK$ H17 earnings beat, 2017 growth guidance reaffirmed; TP raised to HK$5.

European Lithium Limited

Company Overview. Financial Performance

Sunway. Another feather to its cap

Gujarat Alkalies and Chemicals Ltd

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Aroundtown Property Holdings Plc.

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

TCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1.

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.

Luk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

4 July 2017 PAION AG. FIRST BERLIN Equity Research. Update. Bloomberg: PA8 GR Return Potential 44.5% ISIN: DE000A0B65S3

Anta Sports (2020 HK)

Luk Fook (590 HK) Hold (downgraded) Target price: HK$ HFY18 results beat, but downgrade from Accumulate to Hold on rich valuation

Indygotech Minerals S.A.

Zain KSA bogged down by high debt

Gaiam, Inc. Gaiam, Inc. Financial Snapshot. Operating Performance. Fast Facts. SWOT Analysis. [Figure] Gaiam, Inc. - SWOT Profile Page 1

Zain KSA restructuring ensures fresh start

Company Overview. Financial Performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Company Overview. Financial Performance

China Renewable Energy Investment Ltd (987_HK)

Dr Reddy s Laboratories

co.don AG Q1 substantially above last year 13 April 2015

IFRS Financial Ratios

28,491 PRICE: HK$ EARNINGS

Transcription:

FRST BERLN Equity Research NTERSHOP COMMUNCATONS AG GERMANY / TECHNOLOGY Primary Exchange: Frankfurt Bloomberg symbol: SH2 SN: DE000A0EPUH1 NTERSHOP COMMUNCATONS AG OVERVEW 15 December 2010 RATNG: Buy PRCE TARGET: 2.60 RETURN POTENTAL: 29.9% RSK RATNG: High BOARD COMPROMSE REACHED; SHAREHOLDER GROUP TO REMAN ACTVE GS s Attempted Silent Takeover of ntershop has Suffered a Setback. The Extraordinary General Meeting of ntershop took place yesterday in Jena. The meeting had been called by strategic partner and largest shareholder, GS, which sought to take all seats on ntershop s Supervisory Board (SB). As indicated in our previous research on the company, we expected that minority shareholders would try to block GS s move. This expectation has materialized. GS has conceded the Supervisory Board Chairman seat. Dr. Herbert May will remain ntershop s Chairman. This outcome had been negotiated ahead of the EGM between GS and a shareholder group led by Mr. Roland Klauss. Effectively, the only change to the SB was the appointment of Michael R. Conn, GS s CFO, in place of Günter Lorenz. Thus, GS currently control 2 out 3 Supervisory Board seats. Shareholder group to remain active. Mr. Klauss was able to rally EGM shareholders representing an aggregate stake of above 20%. Combined with press coverage and analyst research published in the run-up to the event, this contributed to record high shareholder turn-out of 50.3% at the meeting, which lasted nearly 7 hours. Mr. Klauss gave clear indication that the shareholder group will remain active. Discussions with major investors are underway as the activist group tries to increase its stake in ntershop further. The EGM outcome is positive for ntershop s stock price. GS will retain its stake in ntershop. GS wishes to control the development of Enfinity Suite 7, which is a critically important project for both companies. The activist shareholder group is also seeking to bring new strategic investors into the picture. This implies short-term upward pressure on ntershop s stock. We maintain our BUY rating and 2.60 price target on ntershop. FNANCAL HSTORY & PROJECTONS 2007 2008 2009 2010E 2011E 2012E Revenue ( m) 26.91 28.12 31.78 38.13 42.90 48.80 Y-o-y growth na 4.5% 13.0% 20.0% 12.5% 13.8% EBT ( m) -1.95 1.87 2.00 1.70 3.03 4.28 EBT margin -7.2% 6.7% 6.3% 4.5% 7.1% 8.8% Net income ( m) -2.03 1.50 2.09 1.62 2.73 3.85 EPS (diluted) ( ) -0.08 0.06 0.08 0.06 0.09 0.13 P/E (x) na 33.7 24.5 32.1 21.5 15.3 DPS ( ) 0.00 0.00 0.00 0.00 0.00 0.00 Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% FCF ( m) -6.52 2.78 0.44 6.16 6.33 7.95 Net gearing 1.4% 7.6% 4.2% 12.7% 13.0% 13.5% Liquid assets ( m) 5.95 8.08 6.31 14.19 19,42 26,26 RSKS Risks include, but are not limited to, market share losses, unfavorable macroeconomic developments, and management churn. COMPANY PROFLE ntershop is one of the pioneers of the e- commerce solutions market. ntershop has over 300 customers. The company's target customer base includes mid-market and large enterprise companies. Typical implementation projects include online retail store development, supply chain integration, and online marketing campaigns. TRADNG DATA Closing price (14.12.10) 2.00 Shares outstanding 29.12m Market capitalisation 58.27m 52-week range 1.44/2.20 Avg. vol. (12-mos.) 57,826 STOCK OVERVEW 2,4 2,2 2,0 1,8 1,6 1,4 1,2 Dec 09 Mar 10 Jun 10 Sep 10 ntershop Communications AG COMPANY DATA (as of 30 September 2010) Liquid assets Current assets ntangible assets Total assets Current liabilities Shareholders equity SHAREHOLDERS NMDP ndex 1050 1000 GS Commerce, nc. 27.2% Free float 72.8% 950 900 850 800 750 14.19m 23.42m 8.87m 33.74m 7.78m 23.04m Analyst: Tsvetan Kintisheff, Tel. +49 (0)30-80 93 96 88 0

NCOME STATEMENT ANALYSS All figures in '000 2007A 2008A 2009A 2010E 2011E 2012E Revenues 26,911 28,118 31,777 38,132 42,900 48,800 Cost of goods sold 14,879 16,713 16,866 22,584 24,855 27,438 Gross Profit 12,032 11,405 14,911 15,548 18,045 21,363 SG&A 9,428 7,105 8,355 8,963 9,438 10,736 R&D 2,977 1,228 4,275 4,924 5,577 6,344 Other Operating ncome/expense 1,572 1,201 281-39 0 0 Operating income -1,945 1,871 2,000 1,701 3,030 4,283 Net financial result -217-117 135 3 0 0 ncome before income taxes and minority interests -2,162 1,754 2,135 1,704 3,030 4,283 ncome taxes -129 251 428 171 303 428 Minority interests 0 0 382 86 0 0 Net income / loss -2,033 1,503 2,089 1,619 2,727 3,854 EPS -0.08 0.06 0.08 0.06 0.09 0.13 Diluted EPS -0.07 0.05 0.08 0.06 0.09 0.13 EBTDA -995 2,346 3,765 3,984 5,530 7,283 Ratios Gross margin 44.7% 40.6% 46.9% 40.8% 42.1% 43.8% EBT-Margin -7.2% 6.7% 6.3% 4.5% 7.1% 8.8% EBTDA margin -3.7% 8.3% 11.8% 10.4% 12.9% 14.9% Net ncome Margin -7.6% 5.3% 6.6% 4.2% 6.4% 7.9% Tax Rate n.m. 14.3% 20.0% 10.0% 10.0% 10.0% Expenses as % of revenues SG&A 35.0% 25.3% 26.3% 23.5% 22.0% 22.0% R&D 11.1% 4.4% 13.5% 12.9% 13.0% 13.0% Other Operating ncome/expense 5.8% 4.3% 0.9% -0.1% 0.0% 0.0% Y-Y Growth Total revenues 0.0% 4.5% 13.0% 20.0% 12.5% 13.8% Operating income 0.0% n.m. 6.9% -15.0% 78.2% 41.3% Net income/ loss 0.0% n.m. 39.0% -22.5% 68.5% 41.3% 1

BALANCE SHEET ANALYSS All figures in '000 2007A 2008A 2009A 2010E Assets Current Assets, Total 15,798 15,709 17,873 23,420 Cash and Cash Equivalents 5,949 8,082 6,314 14,188 Trade accounts and notes receivables 4,760 5,713 10,569 7,428 Receivables to Associated Parites 2,736 383 383 383 nventories 2,353 1,531 607 1,421 Non-Current Assets, Total 7,368 9,160 10,868 9,519 Goodwill + ntangible Assets 5,639 7,526 9,504 8,867 Property, plant and Equipment 459 467 571 652 Other Assets 1,270 1,167 793 0 Total Assets 23,166 24,869 28,741 33,739 Shareholders' Equity & Debt Current Liabilities, Total 10,622 7,297 9,559 7,781 Trade payables 3,294 2,536 3,862 3,263 Short Term Debt + CP of LTD 2,001 0 0 0 Current provisions 1,764 2,000 2,230 2,065 Short term finance leases 134 664 1,054 0 Other current liabilities 3,429 2,097 2,413 2,453 Longterm Liabilities, Total 178 1,237 786 2,922 Long Term Debt 0 0 0 0 Deferred Revenue 16 623 307 2,453 Other Liabilities 162 614 479 469 Shareholders Equity, Total 12,366 16,335 18,723 23,036 Share Capital 24,879 26,193 26,309 29,120 Capital Reserve 5,678 6,579 6,728 7,465 Other Reserves 1,869 2,120 2,154 2,240 Loss carryforward / retained eranings -20,060-18,557-16,468-15,789 Minority interests 0 0-327 0 Total Consolidated Equity and Debt 23,166 24,869 29,068 33,739 Ratios Current ratio 1.49 2.15 1.87 3.01 Quick ratio 1.01 1.89 1.77 2.78 Equity ratio (as%) 53.4% 65.7% 63.3% 68.3% Debt to equity ratio (gearing as %) 1.4% 7.6% 4.2% 12.7% Equity per share 0.43 0.59 0.69 23036.00 Net cash 3,948 8,082 6,314 14,188 nterest coverage ratio - 5 667 77 Capital employed (CE) 11,274 16,405 18,389 25,158 Return on Equity (ROE) n.m 0.09 0.11 0.07 Return on capital employed (ROCE) n.m 9.2% 11.4% 6.4% Return on net assets (RONA) n.m 6.0% 7.3% 4.8% Days of inventory turnover 0.00 0.00 0.00 0.00 Days of sales outstanding (DSO) 61 71 86 65 2

CASH FLOW ANALYSS All figures in '000 2007A 2008A 2009A 2010E 2011E 2012E Net ncome -2,033 1,503 2,089 1,619 2,727 3,854 Depreciation and amortization 950 475 1,765 2,283 2,500 3,000 nvestment in working capital -6,415 316-3,485 2,495 0 0 Others 1,168 747 458 164 0 0 Operating Cashflow -6,330 3,041 827 6,561 5,227 6,854 CAPEX -193-263 -389-400 -400-400 nvestments in ntangibles -30-2,106-2,505-1,050 0 0 Free cashflow -6,553 672-2,067 5,111 4,827 6,454 Debt Financing 0-964 0 0 0 0 Equity Financing 5,397 403 104 4,000 0 0 Other Changes in Cash 3,476 2,021 196-15 0 0 Change in Cash 2,320 2,132-1,767 9,096 5,227 6,854 Cash, start of the year 3,629 5,949 8,082 6,314 14,188 19,415 Cash, end of the year 5,949 8,082 6,314 14,188 19,415 26,269 Cashflow per share in 0.09 0.08-0.06 0.32 0.17 0.23 Y-Y Growth Operating Cashflow 0.0% n.m. -72.8% 693.3% -20.3% 31.1% Free cashflow 0.0% n.m. n.m. n.m. -5.5% 33.7% Cashflow per share 0.0% -9.3% n.m. n.m. -46.2% 30.0% 3

FRST BERLN RECOMMENDATON & PRCE TARGET HSTORY Report No.: Date of publication Previous day closing price Recommendation Price target nitial Report 18 November 2010 2.002 Buy 2.60 nterim Update 18 November 2010 2.00 Buy 2.60 1 2 3 4 Today 2.00 Buy 2.60 Disclaimer F R S T B E R L N D S C Tsvetan Kintisheff First Berlin Equity Research GmbH Mohrenstraße 34 10117 Berlin Tel. +49 (0)30-80 93 96 88 Fax +49 (0)30-80 93 96 87 info@firstberlin.com www.firstberlin.com FRST BERLN POLCY n an effort to assure the independence of First Berlin research neither analysts nor the company itself trade or own securities in subject companies. n addition, analysts compensation is not directly linked to specific financial transactions, trading revenue or asset management fees. Analysts are compensated on a broad range of benchmarks. Furthermore, First Berlin receives no compensation from subject companies in relation to the costs of producing this report. ANALYST CERTFCATON, Tsvetan Kintisheff, certify that the views expressed in this report accurately reflect my personal and professional views about the subject company; and certify that my compensation is not directly linked to any specific financial transaction including trading revenue or asset management fees; neither is it directly or indirectly related to the specific recommendation or views contained in this research. n addition, possess no shares in the subject company. NVESTMENT RATNG SYSTEM First Berlin s investment rating system is five tiered and includes an investment recommendation and a risk rating. Our recommendations, which are a function of our expectation of total return (forecast price appreciation and dividend yield) in the year specified, are as follows: STRONG BUY: Expected return greater than 50% and a high level of confidence in management s financial guidance BUY: Expected return greater than 25% ADD: Expected return between 0% and 25% REDUCE: Expected negative return between 0% and -15% SELL: Expected negative return greater than -15% Our risk ratings are Low, Medium, High and Speculative and are determined by ten factors: corporate governance, quality of earnings, management strength, balance sheet and financing risk, competitive position, standard of financial disclosure, regulatory and political uncertainty, company size, free float and other company specific risks. These risk factors are incorporated into our valuation models and are therefore reflected in our price targets. Our models are available upon request to First Berlin clients. Up until 16 May 2008, First Berlin s investment rating system was three tiered and was a function of our expectation of return (forecast price appreciation and dividend yield) over the specified year. Our investment ratings were as follows: BUY: expected return greater than 15%; HOLD: expected return between 0% and 15%; and SELL: expected negative return. ADDTONAL DSCLOSURES This report is not constructed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer would be illegal. We are not soliciting any action based upon this material. This material is for the general information of clients of First Berlin. t does not take into account the particular investment objectives, financial situation or needs of individual clients. Before acting on any advice or recommendation in this material, a client should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The material is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should be relied upon as such. Opinions expressed are our current opinions as of the date appearing on this material only; such opinions are subject to change without notice. Copyright 2008 First Berlin Equity Research GmbH. All rights reserved. No part of this material may be copied, photocopied or duplicated in any form by any means or redistributed without First Berlin s prior written consent. The research is not for distribution in the USA or Canada. When quoting please cite First Berlin as the source. Additional information is available upon request. 4